clinical trial · NCT06858332
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Atherosclerotic Cardiovascular DiseaseAtorvastatinSimvastatinRozuvastatinEzetimibeNiacinCiprofibrateFenofibrateBezafibrate
brief summary
This study has the purpose to answer how the Lipoprotein(a) (Lp(a)) level is distributed among Atherosclerotic cardiovascular disease (ASCVD) patients in Russia, and what is the connection between elevated levels of this parameter and the cardiovascular disease (CVD) risk.
started
Apr 15, 2025
primary completion
Sep 30, 2027
completion
Sep 30, 2027
last updated
Aug 3, 2025
detailed description
This study will consist of several phases (consecutive stages):
Phase I: a cross-sectional study of Lp(a) level with ASCVD patients
Phase II:
* A non-interventional, prospective, cohort study with the phase I patients * A cross-sectional study of Lp(a) levels with relatives of phase I patients * A non-interventional, prospective, cohort study with patients' relatives
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol